SB 0152 — AN ACT to amend Tennessee Code Annotated, Title 53; Title 63 and Title 68, relative to stem cell treatment.
Last action — Rcvd. from S., held on H. desk.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill has passed the Senate. Introduced January 15, 2025. It now moves to the second chamber.
Next likely step: consideration and a floor vote in the House.
Prognosis
Where this bill stands today.
Odds of enactment
ModerateHow often bills like it became law.
-
Passed Senate
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 R).
-
Cleared a recorded vote
Passed 1 recorded vote so far.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Health Care - As introduced, authorizes a patient with a severe chronic disease or terminal illness to access, and a physician to recommend, investigational stem cell treatment; requires the commissioner of health to promulgate rules to, among other things, list the medical conditions that constitute a qualifying severe chronic disease or terminal illness. - Amends TCA Title 53; Title 63 and Title 68.
Bill Text
- Full text View text Current pdf
Action History
-
Filed for introduction
-
Intro., P1C.
-
P2C, ref. to Health Committee- Government Operations for Review
-
Assigned to s/c Health Subcommittee
-
Placed on s/c cal Health Subcommittee for 3/4/2026
-
Action Def. in s/c Health Subcommittee to 3/11/2026
-
Placed on s/c cal Health Subcommittee for 3/11/2026
-
Action Def. in s/c Health Subcommittee to 3/18/2026
-
Placed on s/c cal Health Subcommittee for 3/18/2026
-
Taken off notice for cal in s/c Health Subcommittee of Health Committee
-
Filed for introduction
-
Introduced, Passed on First Consideration
-
Passed on Second Consideration, refer to Senate Health and Welfare Committee
-
Placed on Senate Health and Welfare Committee calendar for 3/26/2025
-
Recommended for passage, refer to Senate Calendar Committee
-
Placed on Senate Consent Calendar 2 for 3/31/2025
-
Passed Senate, Ayes 30, Nays 0
-
Engrossed; ready for transmission to House
-
Rcvd. from S., held on H. desk.
Sponsors
- Mark Pody · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 132 not signed on
Sponsors (1)
- Pody, Mark Republican
Co-sponsors (0)
None.
Not signed on (132)
132 members have not signed on to this bill.
Show all 132 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
Roll call published as PDF — view source.
Subjects
Frequently asked questions
- What does SB 0152 do?
- Health Care - As introduced, authorizes a patient with a severe chronic disease or terminal illness to access, and a physician to recommend, investigational stem cell treatment; requires the commissioner of health to promulgate rules to, among other things, list the medical conditions that constitute a qualifying severe chronic disease or terminal illness. - Amends TCA Title 53; Title 63 and Title 68.
- Who sponsors SB 0152?
- SB 0152 is sponsored by Pody, Mark (Republican).
- What is the current status of SB 0152?
- This bill has passed the Senate. Introduced January 15, 2025. It now moves to the second chamber.
- Where can I track SB 0152?
- Track SB 0152 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 0152
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 0152
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →